Factors associated with the development of acute myocardial infarction in patients with COVID-19
DOI:
https://doi.org/10.33448/rsd-v11i8.30792Keywords:
COVID-19; SARS-CoV-2; Myocardial infarction; Coronary thrombosis.Abstract
Objective: To describe the factors associated with the development of Acute Myocardial Infarction (AMI) in patients with COVID-19. Methodology: This is an integrative literature review, with the purpose of gathering and synthesizing results of investigations on the subject. For the selection of studies, PubMed (North American Biomedical Literature, created by the US National Library of Medicine), Web of Science and Scopus databases were searched, from January to March 2022. The descriptors used were: (COVID-19) OR (SARS-CoV-2) AND (MYOCARDIAL INFARCTION) AND (CORONARY THROMBOSIS). The final sample consisted of 08 analyzed articles. Results: The main factors that are associated with the occurrence of AMI in patients positive for COVID-19 are: the advanced age of the individuals, patients with high comorbidities and being male. The most common alterations in clinical and laboratory tests are the elevation of the st segment on the electrocardiogram, increased levels of troponin, D-dimer and serum C-reactive protein. The association between these factors represents a greater severity of these patients with a higher mortality rate. Conclusion: Knowledge of information regarding the baseline characteristics of cases associated with acute myocardial infarction (AMI) to patients with COVID-19 contributes to organizing the management of these patients in hospital systems through the institution of appropriate protocols for rapid diagnosis, screening and isolation. And also to minimize the exposure of the health team.
References
Alaarag, A., Hassan, T., Samir, S., & Naseem, M. (2020). Clinical and angiographic characteristics of patients with STEMI and confirmed diagnosis of COVID-19: an experience of Tanta University Hospital. The Egyptian Heart Journal. 72(10), 1-6. https://doi.org/10.1186/s43044-020-00103-y
Bakhshi, H., Donthi, N., Ekanem, E., & Batchelor, W. (2020). The clinical spectrum of myocardial injury associated with COVID-19 infection. Journal of Community Hospital Internal Medicine Perspectives, 10(6), 521-522. https://doi.org/10.1080/20009666.2020.1809910
Brasil. (2022). Sistema de informações de mortalidade. Óbitos por residência por ano do óbito segundo capítulo CID-10. Dados preliminares de mortalidade 2022. Datasus. http://www.datasus.gov.br
Brizola, J., & FANTIN, N. (2016). Revisão da literatura e revisão sistemática da literatura. Revista de Educação do Vale do Arinos-RELVA, 3(2). https://doi.org/10.30681/relva.v3i2.1738
Choudry, F. A., Hamshere, S.M., Rathod, K.S., & Jones, D. A. (2020). High thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology, 76(10), 1168-1176. https://doi.org/10.1016/J.JACC.2020.07.022
Esposito, L., Cancro, F. P., Silverio, A., & Galasso, G. (2021). COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives. Oxidative Medicine and Cellular Longevity, 2021(13). https://doi.org/10.1155/2021/4936571
Galvão, C. M. (2006). Niveles de evidencia. Acta Paulista de Enfermagem, 19(2), 5-5.
Galvão, M. H., & Rodrigues; R. A., (2021). Fatores associados a maior risco de ocorrência de óbito por COVID-19: análise de sobrevivência com base em casos confirmados. Revista brasileira de epidemiologia, 23. https://doi.org/10.1590/1980-549720200106
Galvão, T. F., Pansani, T. D. S. A., & Harrad, D. (2015). Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiologia e serviços de saúde, 24(2), 335-342. http://dx.doi.org/10.5123/S1679-49742015000200017
Guimarães, R.B., Falcão, B., Costa, R.A., & Sarmento-Leite, R. (2020). Síndromes coronarianas agudas no contexto atual da pandemia COVID-19. Arquivos Brasileiros de Cardiologia, 114(6), 1067-1071. http://dx.doi.org/10.36660/abc.20200358
Hamadeh, A., Aldujeli, A., Briedis, K., & McCullough, P. A. (2020). Characteristics and outcomes in patients presenting with COVID-19 and ST-segment elevation myocardial infarction. The American journal of cardiology, 131, 1-6. https://doi.org/10.1016/j.amjcard.2020.06.063
Jalali, F., Hatami, F., Saravi, M., & Ziaie, N. (2021). Characteristics and outcomes of hospitalized patients with cardiovascular complications of COVID-19. Journal of Cardiovascular and Thoracic Research, 13(4), 355-363. https://doi.org/10.34172/jcvtr.2021.53
Kelham, M., Choudry, F.A., Hamshere, S., & Jones, D.A. (2021). Therapeutic implications of COVID-19 for the interventional cardiologist. Journal of Cardiovascular Pharmacology and Therapeutics, 26(3), 203-216. https://doi.org/10.1177/1074248420982736
Kiris, T., Avci, E., Ekin, T., & Ergene, A.O. (2021). Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry). Journal of thrombosis and thrombolysis, 53(2), 321-334. https://doi.org/10.1007/s11239-021-02487-3
Kite, T. A., Ludman, P. F., Gale, C. P., & International COVID-ACS Registry Investigators. (2021). International prospective registry of acute coronary syndromes in patients with COVID-19. Journal of the American College of Cardiology, 77(20), 2466-2476. https://doi.org/10.1016/J.JACC.2021.03.309
Lang, J. P., Wang, X., Moura, F. A., Siddiqi, H. K., Morrow, D. A., & Bohula, E. A. (2020). A current review of COVID-19 for the cardiovascular specialist. American heart journal, 226, 29-44. https://doi.org/10.1016/J.AHJ.2020.04.025
Levi, M., Thachil J., Iba T., & Levy JH. (2020). Anormalidades de coagulação e trombose em pacientes com COVID-19. Lanceta Hematol. 7, 438–440.
Li, L. Q., Huang, T., Wang, Y. Q., & Wang, Y. (2020). COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis. Journal of medical virology, 92(6), 577-583. https://doi.org/10.1002/jmv.25757
Lippi, G., & Favaloro, E. J. (2020). D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thrombosis and haemostasis, 120(05), 876-878. http://doi.org/10.1055/s-0040-1709650
Matsushita, K., Hess, S., Marchandot, B., & Morel, O. (2021). Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic. Journal of thrombosis and thrombolysis, 52(1), 95-104. http://doi.org/10.1007/S11239-020-02340-Z/FIGURES/3
Mendes, K. D., Silveira, C. P., & Galvão, C. M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & contexto-enfermagem, 17, 758-764. https://doi.org/10.1590/S0104-07072008000400018
Mendes, K. D., Silveira, C. P., & Galvão, C. M. (2019). Use of the bibliographic reference manager in the selection of primary studies in integrative reviews. Texto & Contexto-Enfermagem, 28. https://doi.org/10.1590/1980-265X-TCE-2017-0204
Moher, D., Liberati, A., Tetzlaff, J., & Tugwell, P. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (Chinese edition). Journal of Chinese Integrative Medicine, 7(9), 889-896. https://doi.org/10.7326/0003-4819-151-4-200908180-00135
Montero-Cabezas, J. M., Córdoba-Soriano, J. G., Díez-Delhoyo, F., & Jurado-Román, A. (2021). Angiographic and clinical profile of patients with COVID-19 referred for coronary angiography during SARS-CoV-2 outbreak: results from a collaborative, european, multicenter registry. Angiology, 73(2), 112-119. https://doi.org/10.1177/00033197211028760
Organização Mundial de Saúde. (2021). Coronavirus disease (COVID-19) outbreak. Geneva: World Health Organization. https://www.paho.org/pt/brasil
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016). Rayyan—a web and mobile app for systematic reviews. Systematic reviews, 5(1), 1-10. https://doi.org/10.1186/S13643-016-0384-4/FIGURES/6
Page, M. J., Moher, D., Bossuyt, P. M., & McKenzie, J. E. (2021). PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. Bmj, 372(160). https://doi.org/10.1136/bmj.n160
Rodriguez-leor, O., Cid-Alvarez, B., de Prado, A. P., & Moreno, R. (2021). In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients. EuroIntervention, 16 (17), 1426-1433. https://doi.org/10.4244. EIJ-D-20-00935 33164893.
Salinas, P., Travieso, A., Vergara-Uzcategui, C., & Fernández-Ortiz, A. (2021). Clinical profile and 30-day mortality of invasively managed patients with suspected acute coronary syndrome during the COVID-19 outbreak. International Heart Journal, 62(2) 20-574. https://doi.org/10.1536/IHJ.20-574
Santos, C. M., Pimenta, C. A., & Nobre, M. R. (2007). A estratégia PICO para a construção da questão de pesquisa e a busca de evidências. Revista Latino-Americana de Enfermagem, 15(3), 508-511. https://doi.org/10.1590/S0104-11692007000300023
Solano-López, J., Zamorano, J. L., Sanz, A. P., & Sánchez-Recalde, Á. (2020). Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak. Revista Española de Cardiología (English Edition), 73(12), 985-993. https://doi.org/10.1016/j.rec.2020.07.009
Souza, M. T., Silva, M. D., & Carvalho, R. D. (2010). Revisão integrativa: o que é e como fazer. Einstein (São Paulo), 8(1) 102-106. https://doi.org/10.1590/S1679-45082010RW1134
Strabelli, T. M., & Uip, D. E. (2020). COVID-19 e o Coração. Arquivos Brasileiros de Cardiologia, 114(4), 598-600. https://doi.org/10.36660/abc.20200209
Whittemore, R., & Knafl, K. (2005). Uma revisão integrativa: uma metodologia atualizada. J Adv Nurs, 52(5), 546-53. https://doi.org/10.1111/j.1365-2648.2005.03621.x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Cleyton Albuqeurque do Nascimento; Ariany Cristine do Nascimento Farias; Raiana Fernanda da Silva Santos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
